The IVF services market is segmented by cycle type into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor egg IVF cycles. The fresh IVF cycles (non-donor) market was the largest segment of the IVF services market segmented by cycle type, accounting for 45.07% or $8.82 billion of the total in 2024. Going forward, the fresh IVF cycles (non-donor) segment is expected to be the fastest growing segment in the IVF services market segmented by cycle type, at a CAGR of 11.77% during 2024-2029.
The IVF services market is segmented by service provider into fertility clinics, hospitals, surgical centers and clinical research institutes. The fertility clinics market was the largest segment of the IVF services market segmented by service provider, accounting for 76.36% or $14.95 billion of the total in 2024. Going forward, the fertility clinics segment is expected to be the fastest growing segment in the IVF services market segmented by service provider, at a CAGR of 11.89% during 2024-2029.
Western Europe was the largest region in the IVF services market, accounting for 31.89% or $6.24 billion of the total in 2024. It was followed by North America, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the IVF services market will be Eastern Europe and South America where growth will be at CAGRs of 13.86% and 12.11% respectively. These will be followed by Asia-Pacific and Middle East where the markets are expected to grow at CAGRs of 11.99% and 11.36% respectively.
The global IVF services markets are fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 7.90% of the total market in 2023. IVIRMA Global was the largest competitor with a 2.63% share of the market, followed by Monash IVF Group with 1.46%, Thomson Medical Group Ltd, with 0.80%, Virtus Health Ltd. with 0.80%, Max Healthcare Institute Limited. with 0.51%, San Diego Fertility Center Inc. with 0.50%, Vitrolife AB with 0.38%, Indira IVF Hospital Ltd. with 0.37%, Genea Limited. with 0.25% and Progyny Inc. with 0.20%.
The top opportunities in the IVF services market segmented by cycle type will arise in the fresh IVF cycles(non-donor) segment, which will gain $6.56 billion of global annual sales by 2029. The top opportunities in the IVF services market segmented by service provider will arise in the fertility clinics segment, which will gain $11.26 billion of global annual sales by 2029. The IVF services market size will gain the most in the USA at $4.06 billion.
Market-trend-based strategies for the IVF services market include integrating AI and regional outreach to transform fertility care, expanding fertility access through strategic partnerships in regional markets and advancing embryo selection with whole genome sequencing in IVF services.
Player-adopted strategies in the IVF services market include a focus on expanding its business capabilities through strategic partnerships and through acquisitions.
This report describes and explains the IVF services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global IVF services market reached a value of nearly $19.57 billion in 2024, having grown at a compound annual growth rate (CAGR) of 7.89% since 2019. The market is expected to grow from $19.57 billion in 2024 to $33.67 billion in 2029 at a rate of 11.46%. The market is then expected to grow at a CAGR of 10.74% from 2029 and reach $56.09 billion in 2034.
Growth in the historic period resulted from rising infertility rates, delayed parenthood, growth of fertility clinics, government initiatives and increasing incidence of lifestyle disorders. Factors that negatively affected growth in the historic period were the high cost of IVF treatment and limited insurance coverage.
Going forward, increasing awareness and acceptance of IVF, favorable regulatory reforms in developed markets, rising maternal age and expansion of IVF service providers in emerging markets will drive growth. Factor that could hinder the growth of the IVF services market in the future include legal and ethical concerns and lack of skilled professionals.
To take advantage of the opportunities, the analyst recommends the IVF services companies to focus on innovation and regional expansion, focus on advancing genetic testing in IVF procedures, focus on expanding fresh IVF cycles and leveraging technological advancements, expand in emerging markets, focus on strategic partnerships and technology integration, focus on competitive and tiered pricing to maximize market reach and profitability, focus on digital channels and international patient acquisition, focus on physician referrals and professional networks and focus on expanding fertility clinic services to maximize growth.
This product will be delivered within 3-5 business days.
The IVF services market is segmented by service provider into fertility clinics, hospitals, surgical centers and clinical research institutes. The fertility clinics market was the largest segment of the IVF services market segmented by service provider, accounting for 76.36% or $14.95 billion of the total in 2024. Going forward, the fertility clinics segment is expected to be the fastest growing segment in the IVF services market segmented by service provider, at a CAGR of 11.89% during 2024-2029.
Western Europe was the largest region in the IVF services market, accounting for 31.89% or $6.24 billion of the total in 2024. It was followed by North America, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the IVF services market will be Eastern Europe and South America where growth will be at CAGRs of 13.86% and 12.11% respectively. These will be followed by Asia-Pacific and Middle East where the markets are expected to grow at CAGRs of 11.99% and 11.36% respectively.
The global IVF services markets are fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 7.90% of the total market in 2023. IVIRMA Global was the largest competitor with a 2.63% share of the market, followed by Monash IVF Group with 1.46%, Thomson Medical Group Ltd, with 0.80%, Virtus Health Ltd. with 0.80%, Max Healthcare Institute Limited. with 0.51%, San Diego Fertility Center Inc. with 0.50%, Vitrolife AB with 0.38%, Indira IVF Hospital Ltd. with 0.37%, Genea Limited. with 0.25% and Progyny Inc. with 0.20%.
The top opportunities in the IVF services market segmented by cycle type will arise in the fresh IVF cycles(non-donor) segment, which will gain $6.56 billion of global annual sales by 2029. The top opportunities in the IVF services market segmented by service provider will arise in the fertility clinics segment, which will gain $11.26 billion of global annual sales by 2029. The IVF services market size will gain the most in the USA at $4.06 billion.
Market-trend-based strategies for the IVF services market include integrating AI and regional outreach to transform fertility care, expanding fertility access through strategic partnerships in regional markets and advancing embryo selection with whole genome sequencing in IVF services.
Player-adopted strategies in the IVF services market include a focus on expanding its business capabilities through strategic partnerships and through acquisitions.
This report describes and explains the IVF services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global IVF services market reached a value of nearly $19.57 billion in 2024, having grown at a compound annual growth rate (CAGR) of 7.89% since 2019. The market is expected to grow from $19.57 billion in 2024 to $33.67 billion in 2029 at a rate of 11.46%. The market is then expected to grow at a CAGR of 10.74% from 2029 and reach $56.09 billion in 2034.
Growth in the historic period resulted from rising infertility rates, delayed parenthood, growth of fertility clinics, government initiatives and increasing incidence of lifestyle disorders. Factors that negatively affected growth in the historic period were the high cost of IVF treatment and limited insurance coverage.
Going forward, increasing awareness and acceptance of IVF, favorable regulatory reforms in developed markets, rising maternal age and expansion of IVF service providers in emerging markets will drive growth. Factor that could hinder the growth of the IVF services market in the future include legal and ethical concerns and lack of skilled professionals.
To take advantage of the opportunities, the analyst recommends the IVF services companies to focus on innovation and regional expansion, focus on advancing genetic testing in IVF procedures, focus on expanding fresh IVF cycles and leveraging technological advancements, expand in emerging markets, focus on strategic partnerships and technology integration, focus on competitive and tiered pricing to maximize market reach and profitability, focus on digital channels and international patient acquisition, focus on physician referrals and professional networks and focus on expanding fertility clinic services to maximize growth.
This product will be delivered within 3-5 business days.
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Major Market Trends
8 Global IVF Services Growth Analysis And Strategic Analysis Framework
9 Global IVF Services Market Segmentation
10 IVF Services Market, Regional and Country Analysis
11 Asia-Pacific Market
12 Western Europe Market
13 Eastern Europe Market
14 North America Market
15 South America Market
16 Middle East Market
17 Africa Market
18 Competitive Landscape And Company Profiles
19 Other Major And Innovative Companies
22 Key Mergers And Acquisitions
23 Recent Developments In The IVF Services Market
24 Opportunities And Strategies
25 IVF Services Market, Conclusions And Recommendations
26 Appendix
Executive Summary
IVF Services Global Market Opportunities And Strategies To 2034 provides the strategists; marketers and senior management with the critical information they need to assess the global IVF services market as it emerges from the COVID-19 shut down.Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for IVF services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The IVF services market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider IVF services market; and compares it with other markets.
The report covers the following chapters
- Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by cycle type and by service provider.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis And Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by cycle type and by service provider in the market.Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size And Growth - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard - Briefs on competitive dashboard of major players.
- Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments - Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations - This section includes recommendations for IVF services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Cycle Type: Fresh IVF Cycles (Non-Donor); Thawed IVF Cycles (Non-Donor); Donor Egg IVF Cycles2) By Service Provider: Fertility Clinics; Hospitals; Surgical Centers; Clinical Research Institutes
Key Companies Profiled: IVIRMA Global; Monash IVF Group; Thomson Medical Group Ltd.; Virtus Health Ltd.; Max Healthcare Institute Limited.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; IVF services indicators comparison.
Data segmentations:country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing:Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- IVIRMA Global
- Monash IVF Group
- Thomson Medical Group Ltd.
- Virtus Health Ltd.
- Max Healthcare Institute Limited.
- San Diego Fertility Center Inc.
- Vitrolife AB
- Indira IVF Hospital Lt
- Genea Limited
- Progyny Inc.
- Gameto
- Liverpool
- Indian Immunologicals Limited (IIL)
- Sabine Hospital
- Nova IVF Fertility
- Santaan
- Kedaara Capital
- Gulf Capital
- Virtus Health Limited
- Monash IVF Group
- Genea Limited
- Morula IVF Indonesia
- Recharge Capital
- Renji Hospital
- Lunar
- Jinxin Fertility Group Limited
- Zhongshan Boai Hospital
- Beijing Perfect Family Hospital
- Zhejiang Women's Hospital
- Chengdu Xinan Gynecology Hospital
- REPROCELL
- Memphasys
- Dioseve
- Oak Clinic Group
- Yamashita Shonan Yume Clinic
- Hiroo Ladies Clinic
- Kamijo Women's Clinic
- Kitazato Corporation
- Tawara IVF Clinic
- CHA Medical Group (CHA Fertility Center)
- Maria Fertility Hospital
- Seoul Women’s Hospital
- MizMedi Hospital
- Mamapapa Fertility Center
- IVF Phuong Chau Saigon
- FV Hospital
- OLEA Fertility
- Hong Ngoc IVF Center
- Andrology and Fertility Hospital of Hanoi
- IVF Van Hanh
- Apricity
- Vivaneo
- Fertility Center Hamburg GmbH
- GeneraLife IVF
- CARE Fertility
- Create Fertility
- London Women’s Clinic
- Impilo
- The Fertility Partnership (TFP)
- Ava-Peter Clinic
- IVF Russia (The International Centre of The Reproductive Medicines)
- Next Generation Clinic
- Scandinavia AVA-Peter
- Nova Vita Clinic
- Gyncentrum Fertility Clinic
- INVICTA Fertility Clinics
- Inception Fertility, LLC
- Cryoport, Inc.
- ReproTech LLC
- The Prelude Network
- INVO Bioscience, Inc
- The Cooper Companies, Inc.
- Progyny
- Xytex Corporation
- Quantum Health
- Thermo Fisher Scientific, Inc.
- Merck & Co., Inc.
- Cook Medical Inc.
- Fertility Centers of Illinois
- Boston IVF
- EMD Serono Inc.
- Carolinas Fertility Institute
- Fertility Focus
- Pinnacle Fertility
- Ovation Fertility
- US Fertility
- CNY Fertility
- Wisconsin Fertility Institute
- Ottawa Fertility Clinic
- New Hope Fertility Center
- IntegraMed America
- NewLife Fertility Centre
- Dallas Fort Worth Fertility Associates
- Overlake Reproductive Health
- Fertility Center of Las Vegas
- Duke Fertility Center
- Advanced Fertility Center of Texas
- Cleveland Clinic Fertility Center
- NYU Langone Fertility Center
- IVF Canada
- Fertility Match
- IVF Vallarta
- Bio Fertility Center
- Fertility Center Cancun
- Nova IVF
- Femasys Inc.
- FemaSeed
- Medavie Blue Cross
- Carrot Fertility
- Clínica Dale
- MaisFert
- Oya Care
- Select IVF
- Fertility Argentina
- Fertility Patagonia
- In Vitro Buenos Aires
- Inser
- Halitus Instituto Medico
- Pregna Medicina Reproductiva
- Aphrodite Egg Bank
- Fakih IVF Fertility Center
- Bourn Hall Fertility Clinic
- Clalit IVF Center
- Assuta Medical Center
- Hadassah Fertility Center
- AIVF
- Gargash Hospital
- Orchid Fertility Center
- Medfem Fertility Clinic
- VitaLab Fertility Clinic
- Cape Fertility Clinic
- Fertility Clinic Johannesburg
- Sandton Fertility Clinic
- The Nairobi Hospital
- Family Fertility Centre
- Fertility Options
- IVF Uganda
- Women's Hospital International and Fertility Centre
- Assiut University Hospital
- Cairo Fertility Clinic
- Nile Fertility Center
- Salah Dawood Clinic
- BPE Partners
- Cleopatra Hospitals Group (CHG)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 305 |
| Published | June 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 19.57 Billion |
| Forecasted Market Value ( USD | $ 56.09 Billion |
| Compound Annual Growth Rate | 11.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 144 |
